Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection
Clinical trial NCT04361903 · UNKNOWN
Trial details
- NCT number
- NCT04361903
- Sponsor
- Azienda USL Toscana Nord Ovest
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-25
- Primary completion
- 2020-05-24
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.